What is Multiphoton Optics?
Multiphoton Optics operates at the intersection of advanced photonics and industrial manufacturing. As a key player in the nanofabrication ecosystem, the company provides sophisticated maskless direct write lithography systems that enable high-resolution surface structuring. Their technological suite is essential for modern micro-optics, semiconductor fabrication, and biomedical engineering, where precision at the sub-micron level is a prerequisite for innovation. With a global installation base and a commitment to customized industrial solutions, the company serves as a critical infrastructure provider for sectors requiring high-throughput, high-fidelity surface engineering.
The company's market position is bolstered by its ability to bridge the gap between laboratory-scale experimentation and high-end industrial production. By offering versatile tools that cater to both R&D environments and large-scale manufacturing, Multiphoton Optics maintains a competitive edge in the rapidly evolving landscape of advanced packaging and micro-device development.
How much funding has Multiphoton Optics raised?
Multiphoton Optics has raised a total of $850K across 1 funding round:
Angel/Seed
$850K
Angel/Seed (2014): $850K with participation from the Fraunhofer Gesellschaft e.V. and High-Tech Grunderfonds
Key Investors in Multiphoton Optics
the Fraunhofer Gesellschaft e.V.
A leading European research organization that bridges the gap between fundamental science and industrial application, often acting as a strategic partner for deep-tech commercialization.
High-Tech Grunderfonds
HTGF is a pre-seed and seed investor focusing on high-tech startups. The company supports tech founders who have the courage to shape the future, offering a strong network in both industry and academia, as well as deep tech expertise.
What's next for Multiphoton Optics?
With the recent capital deployment, Multiphoton Optics is expected to focus on scaling its production capacity and expanding its global service network. The strategic roadmap likely involves enhancing the throughput of its lithography systems to meet the increasing demands of the semiconductor and micro-optics industries. Furthermore, the company is well-positioned to capitalize on the growing trend of miniaturization in biotechnology, where its nanofabrication tools are increasingly vital for diagnostic and therapeutic device development. Future growth will likely be driven by continued investment in R&D to maintain technological leadership, alongside potential strategic partnerships that leverage its existing global footprint to penetrate emerging markets in Asia and North America.
See full Multiphoton Optics company page
